Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Vass

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Cell|October 6, 1989
The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptorsP Martin, W C Vass, J T Schiller, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 13, 2001
Refsum's disease in an Arabian familyE Fertl, D Földy, K Vass, et al.
The Cochrane Database of Systematic Reviews|October 30, 2003
Interventions for normal tension glaucomaT Sycha, C Vass, O Findl, et al.
The British Journal of Ophthalmology|November 26, 2008
Diurnal fluctuation of ocular blood flow parameters in patients with primary open-angle glaucoma and healthy subjectsB Pemp, M Georgopoulos, C Vass, et al.
Molecular Carcinogenesis|May 27, 2003
Regulation of cell morphology and adhesion by the tuberous sclerosis complex (TSC1/2) gene products in human kidney epithelial cells through increased E-cadherin/beta-catenin activityShaowei Li, Richard Braverman, Hongzhen Li, et al.
Journal of Virology|July 1, 1992
Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activityS A Sedman, N L Hubbert, W C Vass, et al.
Current Eye Research|October 23, 1997
Effects of changes in intraocular pressure on human ocular haemodynamicsO Findl, K Strenn, M Wolzt, et al.
Molecular and Cellular Biology|November 1, 1993
Functional role of GTPase-activating protein in cell transformation by pp60v-srcJ E DeClue, W C Vass, M R Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK)Guorong Li, Xiaoli Du, William C Vass, et al.
The New Biologist|April 1, 1991
Tumorigenic transformation of NIH 3T3 cells by the autocrine synthesis of transforming growth factor alphaW D Ju, T J Velu, W C Vass, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Cell|October 6, 1989
The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptorsP Martin, W C Vass, J T Schiller, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 13, 2001
Refsum's disease in an Arabian familyE Fertl, D Földy, K Vass, et al.
The Cochrane Database of Systematic Reviews|October 30, 2003
Interventions for normal tension glaucomaT Sycha, C Vass, O Findl, et al.
The British Journal of Ophthalmology|November 26, 2008
Diurnal fluctuation of ocular blood flow parameters in patients with primary open-angle glaucoma and healthy subjectsB Pemp, M Georgopoulos, C Vass, et al.
Molecular Carcinogenesis|May 27, 2003
Regulation of cell morphology and adhesion by the tuberous sclerosis complex (TSC1/2) gene products in human kidney epithelial cells through increased E-cadherin/beta-catenin activityShaowei Li, Richard Braverman, Hongzhen Li, et al.
Journal of Virology|July 1, 1992
Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activityS A Sedman, N L Hubbert, W C Vass, et al.
Current Eye Research|October 23, 1997
Effects of changes in intraocular pressure on human ocular haemodynamicsO Findl, K Strenn, M Wolzt, et al.
Molecular and Cellular Biology|November 1, 1993
Functional role of GTPase-activating protein in cell transformation by pp60v-srcJ E DeClue, W C Vass, M R Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK)Guorong Li, Xiaoli Du, William C Vass, et al.
The New Biologist|April 1, 1991
Tumorigenic transformation of NIH 3T3 cells by the autocrine synthesis of transforming growth factor alphaW D Ju, T J Velu, W C Vass, et al.
Pageof 12